| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3189748 | Annales de Dermatologie et de Vénéréologie | 2006 | 5 Pages |
Abstract
This study reports a new drug-induced onychopathy. Responsibility of sirolimus is highly suggested. The main pathogenesis hypothesis to explain these nail alterations is inhibition of EGF (epidermal growth factor) pathway by sirolimus.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
E. Mahé, E. Morelon, S. Lechaton, H. Kreis, Y. De Prost, C. Bodemer,